Emily Townsend

Emily is an associate in Goodwin’s Technology and Life Sciences group in London. Emily advises clients on a broad range of corporate matters, with a particular focus on transactions in the technology sector. Emily has experience advising on venture capital and growth equity transactions, mergers and acquisitions and general corporate matters. 

Prior to joining Goodwin, Emily was an associate in the Corporate Technology team at Taylor Wessing LLP.

• Ravelin on its acquisition by Worldpay
• Oxford Quantum Circuits on its $100 million Series B financing
• ETF Partners on its investment in the $75 million Series C financing of Riverlane
• Myricx on its £90 million Series A financing, co-led by Novo Holdings and Abingworth
• Relay Technologies on its $35 million and $10 million financings
• Anaphite on its £10.4 million funding round
• VavaCars on its $37m Series C financing*
• Geopura on its GBP£36 million Series A financing*
• Dawn Capital on its investment into Elwood Technologies as part of a $70 million Series A financing*
• Current Health on an acquisition by Best Buy for $400 million*
• Trustology on its sale to Bitpanda*

*Denotes experience prior to joining Goodwin